Fact CheckerSign in

NCT05445349Completed

Breathing Parameter Measurements for Lung Deposition Simulation

Measurement of Breathing Parameters of Asthma and COPD Patients With Different Degrees of Disease Severity for the Computer Simulation of Lung Deposition of Aerosol Drugs

Source: ClinicalTrials.gov · Last updated 28 Nov 2025

Brief summary (registry, in English)

This study aims to simulate the deposition of aerosol drugs within the airways of asthma and COPD patients based on realistic breathing patterns measured at different pulmonology centers. Further goal of the study is to find correlations between the amount of drug depositing in the lungs and the measured breathing parameters, as well as disease status and demographic data. The results of the study will be part of a major objective targeting the optimization and personalization of aerosol drug therapy.

Status (registry)
Completed
Study type
Observational
Enrollment
163 (actual)
First submitted
27 Jun 2022
Start date
1 Sept 2022
Primary completion date
30 Jun 2024
Lead sponsor
Medisol Development Kft.
Diseases
Asthma, COPD
NCT number
NCT05445349

What you commit to

  • Study type: Observational
  • Participants enrolled: 163
  • From 1 Sept 2022 to the primary completion date, 30 Jun 2024
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • diagnosed heavy, not treated chronic illness

Other

  • the patient doesn't align with any of the criteria mentioned above
  • the patient is incapable of filling out the questionnaire/questionnaires' parts that are accorded to him/her
  • the patient doesn't agree to have data collected of him/her
  • not properly carried out /not evaluable lung function (spirometry) examination

Who the study is looking for

  • diagnosed obstructive lung disease (asthma or COPD)
  • proper usage of inhalation tool after being educated
  • availability of whole body plethysmography measurement data from the last 6 months or the possibility to perform them before the start of the study
  • subject under outpatient/inpatient therapy
  • capable of acting and cooperating

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Debrecen
Coordinator of this site? Confirm its status
DebrecenHungaryUnknown status
St. Borbala Hospital
Coordinator of this site? Confirm its status
TatabányaHungaryUnknown status
Pest County Pulmonology Hospital
Coordinator of this site? Confirm its status
TörökbálintHungaryUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.